Company Filing History:
Years Active: 2018
Title: The Innovations of Robert Lew
Introduction
Robert Lew is an accomplished inventor based in Marlborough, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various neurological disorders. His work has the potential to impact the treatment of conditions such as psychosis, schizophrenia, and Parkinson's disease.
Latest Patents
Robert Lew holds a patent for "D2 receptor modulators and methods of use thereof in the treatment of diseases and disorders." This patent includes heteroaryl compounds, methods of their synthesis, and pharmaceutical compositions. The compounds are designed for the treatment, prevention, and management of various disorders, including CNS and neurological disorders.
Career Highlights
Lew is currently associated with Sunovion Pharmaceuticals Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing new therapeutic options for patients suffering from debilitating conditions.
Collaborations
Some of his notable coworkers include Philip Glyn Jones and Kerry Leigh Spear, who contribute to the collaborative efforts in research and development at Sunovion Pharmaceuticals Inc.
Conclusion
Robert Lew's contributions to the field of pharmaceuticals through his innovative patents and collaborative work highlight his commitment to improving treatment options for neurological disorders. His ongoing efforts are paving the way for advancements in medical science.